Canopy Growth (CGC) Total Debt Growth (3y) (2020 - 2026)
Canopy Growth (CGC) Total Debt Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 92.83% |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -39.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.34% |
| Mar 31, 2026 | -43.96% |
| Dec 31, 2025 | -43.37% |
| Sep 30, 2025 | -45.75% |
| Jun 30, 2025 | -42.88% |
| Mar 31, 2025 | -43.66% |
| Dec 31, 2024 | -35.87% |
| Sep 30, 2024 | -30.56% |
| Jun 30, 2024 | -31.39% |
| Mar 31, 2024 | -29.23% |
| Dec 31, 2023 | -2.49% |
| Sep 30, 2023 | 8.26% |
| Jun 30, 2023 | 29.18% |
| Mar 31, 2023 | 40.69% |
| Mar 31, 2022 | 18.55% |
| Mar 31, 2021 | 472.55% |
| Mar 31, 2020 | 254.34% |